Company Filing History:

7 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

4 out of 2,076

Janssen Pharmaceutica Nv

patents

2 out of 377

Ortho Pharmaceutical Corporation

patents

4. 2 out of 832,680

Other

patents

Years Active: 1997-2010

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7659284 - Thiazolopyridine kinase inhibitors (2010-02-09),

2. 7605154 - Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors (2009-10-20),

3. 7579356 - Thia-tetraazaacenaphthylene kinase inhibitors (2009-08-25),

4. 7427625 - Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors (2008-09-23),

5. 7384979 - Substituted amino acids as erythropoietin mimetics (2008-06-10),

6. 7166601 - Substituted diamine derivatives useful as motilin antagonists (2007-01-23),

7. 7153869 - Substituted amino acids as erythropoietin mimetics (2006-12-26),

8. 7112586 - Substituted diamine derivatives useful as motilin antagonists (2006-09-26),

9. 6967199 - Substituted diamine derivatives useful as motilin antagonists (2005-11-22),

10. 6750369 - Substituted amino acids as erythropoietin mimetics (2004-06-15),

11. 6511980 - Substituted diamine derivatives useful as motilin antagonists (2003-01-28),

12. 6310078 - Substituted amino acids as erythropoietin mimetics (2001-10-30),

13. 5874436 - Triphenylalkyl antimicrobial agents (1999-02-23),

14. 5773469 - Diaryl antimicrobial agents (1998-06-30),

15. 5643950 - Triphenylalkyl antimicrobial agents (1997-07-01),

Title: The Innovative Mind of Sigmond G Johnson

Introduction

Sigmond G Johnson, located in Flemington, NJ, is a prolific inventor with a notable portfolio comprising 15 patents. His work has significantly contributed to the field of pharmaceuticals, particularly in the development of kinase inhibitors. Johnson's inventions focus on harnessing the potential of novel compounds to address complex biological interactions.

Latest Patents

Among his latest patents are innovative compounds including thiazolopyridine kinase inhibitors. This invention introduces a series of novel thiazolopyridines designed to inhibit ATP-protein kinase interactions. Furthermore, he has developed substituted thiazolo [4,5-d]pyrimidines that serve as protein kinase inhibitors, showcasing his commitment to advancing pharmaceutical research and treatment methodologies.

Career Highlights

Throughout his career, Sigmond G Johnson has made significant strides in pharmaceutical innovation. He has worked with renowned companies such as Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV, where he applied his inventive talents to bring forth groundbreaking therapies in the healthcare industry.

Collaborations

Johnson has collaborated with esteemed colleagues, including Peter J Connolly and Steven K Wetter. These partnerships have fostered a creative environment that enhances innovation and leads to the successful development of new therapeutic solutions.

Conclusion

With a strong foundation in pharmaceutical inventions, Sigmond G Johnson continues to impact the field significantly. His contributions enhance our understanding of drug interactions and pave the way for innovative treatments that address critical health issues. As a dedicated inventor, Johnson’s work exemplifies the spirit of innovation within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.